This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information

ESMO, Barcelona, Spain 26-30 September 2019

Sequential treatment with afatinib followed by 3rd generation EGFR-TKI – subgroup analysis of the GIDEON trial: a prospective non-interventional study in EGFR-mutated NSCLC patients in Germany  

Wolfgang Brück, Martin Reck, Barbara Hermes, Eckart Laack, Justyna Rawluk, Rudolf M. Huber, Christopher Hoffmann, Andrea Schüler
Esmo Gideon NIS Poster

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

Effectiveness of afatinib in the clinical practice - first results of the GIDEON trial: ​a prospective non-interventional study in EGFR-mutated NSCLC in Germany

 

Wolfgang M. Brueckl, Eckart Laack, Martin Reck, Frank Griesinger, Helmut Schäfer, Cornelius Kortsik, Tobias Gaska, Justyna Rawluk, Stefan Krüger, Konrad Kokowski, Stephan Budweiser, Andrea Schueler, Stephan Kiessling

esmo_2018_gideon_poster_final.jpg

FOR HEALTHCARE PROFESSIONALS ONLY

links_to_3rd_party.jpg